正在加载视频...

视频加载失败

加载此视频时出现问题。这可能是由于临时网络问题，或视频可能不可用。

A recent study found that ivermectin shrinks the most lethal brain cancer in existence by 70% in just 10 days — with ZERO toxicity. They implanted animals with glioblastoma brain tumors and delivered nano-ivermectin intranasally — driving a dramatic collapse in tumor burden.

Nicolas Hulscher, MPH

262,912 subscribers

30,524 次观看 • 4 个月前 •via X (Twitter)

健康养生科学技术

Anya Rossi• Live Now

Private livecam show

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频

Nano-ivermectin shrinks glioblastoma brain tumors by 70% — with ZERO toxicity. A recent study found intranasal nano-ivermectin suppresses brain cancer in animal models at doses LOWER than the human anti-parasitic dose. This aligns with ivermectin’s 14 anti-cancer mechanisms.

Nano-ivermectin shrinks glioblastoma brain tumors by 70% — with ZERO toxicity. A recent study found intranasal nano-ivermectin suppresses brain cancer in animal models at doses LOWER than the human anti-parasitic dose. This aligns with ivermectin’s 14 anti-cancer mechanisms.

Nicolas Hulscher, MPH

56,759 次观看 • 5 个月前

🚨LANDMARK STUDY: Intranasal Nano-Ivermectin Shrinks Brain Tumors by 70% — With ZERO Toxicity Ivermectin nanocapsules DESTROY glioblastoma in animal models at doses LOWER than standard human doses. These findings align with ivermectin’s 14 distinct anti-cancer mechanisms.

🚨LANDMARK STUDY: Intranasal Nano-Ivermectin Shrinks Brain Tumors by 70% — With ZERO Toxicity Ivermectin nanocapsules DESTROY glioblastoma in animal models at doses LOWER than standard human doses. These findings align with ivermectin’s 14 distinct anti-cancer mechanisms.

Nicolas Hulscher, MPH

164,580 次观看 • 9 个月前

“There’s literally over 100 studies showing IVERMECTIN has over 12 distinct anti-cancer mechanisms across 12 cancer types. Glioblastoma brain tumors — one of the most lethal cancers in existence — Ivermectin shrunk the glioblastomas 70% in 10 days.” ~Nicolas Hulscher, MPH

“There’s literally over 100 studies showing IVERMECTIN has over 12 distinct anti-cancer mechanisms across 12 cancer types. Glioblastoma brain tumors — one of the most lethal cancers in existence — Ivermectin shrunk the glioblastomas 70% in 10 days.” ~Nicolas Hulscher, MPH

Valerie Anne Smith

30,754 次观看 • 2 个月前

The single LARGEST human study of ivermectin and mebendazole in cancer patients found that the VAST MAJORITY (84.4%) declared CANCER DISAPPEARANCE, TUMOR SHRINKAGE, or CANCER STABILIZATION.

The single LARGEST human study of ivermectin and mebendazole in cancer patients found that the VAST MAJORITY (84.4%) declared CANCER DISAPPEARANCE, TUMOR SHRINKAGE, or CANCER STABILIZATION.

Nicolas Hulscher, MPH

436,660 次观看 • 3 个月前

A SINGLE dose of a newly discovered frog gut bacterium ELIMINATES 100% of cancerous tumors within just a few days in mice. A new landmark study found the natural bacterium Ewingella americana selectively targets, colonizes, and terminates tumors—with NO detectable toxicity. They re-introduced cancer into the cured animals... and the tumors COULD NOT GROW.

A SINGLE dose of a newly discovered frog gut bacterium ELIMINATES 100% of cancerous tumors within just a few days in mice. A new landmark study found the natural bacterium Ewingella americana selectively targets, colonizes, and terminates tumors—with NO detectable toxicity. They re-introduced cancer into the cured animals... and the tumors COULD NOT GROW.

Nicolas Hulscher, MPH

535,876 次观看 • 17 天前

A SINGLE dose of a newly discovered frog gut bacterium COMPLETELY ERADICATES 100% of cancerous tumors within just 15 days in mice. Landmark study finds the natural bacterium Ewingella americana selectively targets, colonizes, and eliminates tumors—with NO detectable toxicity. They re-introduced cancer into the cured animals... and the tumors COULDN'T GROW.

A SINGLE dose of a newly discovered frog gut bacterium COMPLETELY ERADICATES 100% of cancerous tumors within just 15 days in mice. Landmark study finds the natural bacterium Ewingella americana selectively targets, colonizes, and eliminates tumors—with NO detectable toxicity. They re-introduced cancer into the cured animals... and the tumors COULDN'T GROW.

Nicolas Hulscher, MPH

89,843 次观看 • 2 个月前

1. "Ivermectin: A Supercharged Cancer Fighter" Ivermectin is proving to be up to 7 times more effective than conventional treatments in disrupting cancer’s survival mechanisms. With just a single dose, it strikes cancer cells through multiple pathways and helps block the formation of new tumors, both at the original site and in areas where cancer might spread. #Fenbendazole #Ivermectin #Cancercure

1. "Ivermectin: A Supercharged Cancer Fighter" Ivermectin is proving to be up to 7 times more effective than conventional treatments in disrupting cancer’s survival mechanisms. With just a single dose, it strikes cancer cells through multiple pathways and helps block the formation of new tumors, both at the original site and in areas where cancer might spread. #Fenbendazole #Ivermectin #Cancercure

Joe Tippens

78,082 次观看 • 8 个月前

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.

Nicolas Hulscher, MPH

90,113 次观看 • 5 个月前

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Dr. Zakaria MD

45,356 次观看 • 4 天前

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." #Fenbendazole #Ivermectin #Cancercure

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." #Fenbendazole #Ivermectin #Cancercure

Joe Tippens

166,528 次观看 • 7 个月前

Dr. Drew Shares an Ivermectin Story That 'Broke His Brain' "I was traveling with Peter McCullough...and we were traveling with a guy that got really sick...Peter said take this and this. He gave three things...Ivermectin was one of them. That dude was not just better by the afternoon, he was well and it broke my brain." #ivermectin #Fenbendazole #Mebendazole #Cancercure

Dr. Drew Shares an Ivermectin Story That 'Broke His Brain' "I was traveling with Peter McCullough...and we were traveling with a guy that got really sick...Peter said take this and this. He gave three things...Ivermectin was one of them. That dude was not just better by the afternoon, he was well and it broke my brain." #ivermectin #Fenbendazole #Mebendazole #Cancercure

Joe Tippens

60,985 次观看 • 7 个月前

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

159,980 次观看 • 1 年前

A GROUNDBREAKING study found a SINGLE dose of a newly discovered frog gut bacterium CURED colon cancer in 100% of treated mice. The Ewingella americana bacterium traveled STRAIGHT to the tumors and COMPLETELY ERADICATED them with NO detectable toxicity. When they reintroduced the cancer into the cured mice, the tumors COULDN’T GROW. BB Maguire

A GROUNDBREAKING study found a SINGLE dose of a newly discovered frog gut bacterium CURED colon cancer in 100% of treated mice. The Ewingella americana bacterium traveled STRAIGHT to the tumors and COMPLETELY ERADICATED them with NO detectable toxicity. When they reintroduced the cancer into the cured mice, the tumors COULDN’T GROW. BB Maguire

Nicolas Hulscher, MPH

60,400 次观看 • 2 天前

🚨 BREAKING: Study shows Pfizer birth control shots causing brain tumors Epidemiologist Nicolas Hulscher, MPH speaks with Heather Mullins about a newly published large-scale study examining Pfizer Inc.’s Depo-Provera birth control injections. The study found that women who received the shot faced a 240% increased risk of meningioma, a type of brain tumor that can cause paralysis, chronic pain, and require brain surgery. “A 240% increased risk of disabling brain tumors should never be normalized,” Nicolas Hulscher, MPH said.

🚨 BREAKING: Study shows Pfizer birth control shots causing brain tumors Epidemiologist Nicolas Hulscher, MPH speaks with Heather Mullins about a newly published large-scale study examining Pfizer Inc.’s Depo-Provera birth control injections. The study found that women who received the shot faced a 240% increased risk of meningioma, a type of brain tumor that can cause paralysis, chronic pain, and require brain surgery. “A 240% increased risk of disabling brain tumors should never be normalized,” Nicolas Hulscher, MPH said.

LindellTV

13,444 次观看 • 5 个月前

FROG GUT BACTERIUM COMPLETELY ERADICATES 100% OF CANCEROUS TUMORS AFTER A SINGLE DOSE IN ANIMAL MODELS Ewingella americana selectively targeted and TERMINATED cancer cells via direct tumor destruction & potent immune activation. They re-introduced cancer into the cured mice... and the tumors COULD NOT GROW. The study found NO detectable toxicity at effective doses, and it dramatically outperformed BOTH chemotherapy and immunotherapy.

FROG GUT BACTERIUM COMPLETELY ERADICATES 100% OF CANCEROUS TUMORS AFTER A SINGLE DOSE IN ANIMAL MODELS Ewingella americana selectively targeted and TERMINATED cancer cells via direct tumor destruction & potent immune activation. They re-introduced cancer into the cured mice... and the tumors COULD NOT GROW. The study found NO detectable toxicity at effective doses, and it dramatically outperformed BOTH chemotherapy and immunotherapy.

Nicolas Hulscher, MPH

57,886 次观看 • 1 个月前

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Commentary | Global Ivermectin Research Hub

24,921 次观看 • 24 天前

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Joe Tippens

25,410 次观看 • 26 天前

World Ivermectin Day 2024: "You can use high dose Ivermectin for the majority of Cancers...this is a dose that is 5 to 10 times the dose that people were using for COVID-19". There is no money in treating aggressive cancers with High Dose Ivermectin, Fenbendazole, Mebendazole For example, Fenbendazole and Mebendazole upregulate p53 tumor suppressor levels, that are low in people who took COVID-19 Vaccines and developed Turbo Cancer

World Ivermectin Day 2024: "You can use high dose Ivermectin for the majority of Cancers...this is a dose that is 5 to 10 times the dose that people were using for COVID-19". There is no money in treating aggressive cancers with High Dose Ivermectin, Fenbendazole, Mebendazole For example, Fenbendazole and Mebendazole upregulate p53 tumor suppressor levels, that are low in people who took COVID-19 Vaccines and developed Turbo Cancer

IvermectinKart | Ivermectin & Cancer cure store

1,876,317 次观看 • 8 个月前

Ivermectin is often recognized – 2nd to penicillin – for having the greatest impact on human health. Its discovery even won the Nobel Prize. But the propagandists, like Rachel Maddow, told you it was a “dangerous horse dewormer.” Well, now we are learning that ivermectin has profound anti-cancer properties. Renowned cardiologist Dr. Peter McCullough told Brannon Howse, “There are now multiple papers demonstrating preclinical models that ivermectin has anti-cancer properties.” He added that curcumin, an active compound found in turmeric, also has anti-cancer properties. Ivermectin’s potential as an anti-cancer drug is now being taken seriously, as the Burzynski Center in Texas and the Brio-Medical Center in Arizona are using ivermectin “more in protocol format,” Dr. McCullough revealed. Dr. McCullough is not alone in his optimistic outlook on using ivermectin as a potential cancer treatment. In an interview with The Epoch Times, Cancer surgeon Dr. Kathleen Ruddy revealed that she has seen several late-stage cancer patients make dramatic recoveries after taking ivermectin.

Ivermectin is often recognized – 2nd to penicillin – for having the greatest impact on human health. Its discovery even won the Nobel Prize. But the propagandists, like Rachel Maddow, told you it was a “dangerous horse dewormer.” Well, now we are learning that ivermectin has profound anti-cancer properties. Renowned cardiologist Dr. Peter McCullough told Brannon Howse, “There are now multiple papers demonstrating preclinical models that ivermectin has anti-cancer properties.” He added that curcumin, an active compound found in turmeric, also has anti-cancer properties. Ivermectin’s potential as an anti-cancer drug is now being taken seriously, as the Burzynski Center in Texas and the Brio-Medical Center in Arizona are using ivermectin “more in protocol format,” Dr. McCullough revealed. Dr. McCullough is not alone in his optimistic outlook on using ivermectin as a potential cancer treatment. In an interview with The Epoch Times, Cancer surgeon Dr. Kathleen Ruddy revealed that she has seen several late-stage cancer patients make dramatic recoveries after taking ivermectin.

skymeds store | Online Ivermectin Pharmacy

102,675 次观看 • 1 年前

Three Cancer Patients Defy Odds with Ivermectin: A Doctor’s Call for Urgent Research Dr. Kathleen Ruddy, a breast cancer surgeon, author, and inventor, shared remarkable stories of three patients with advanced, aggressive cancers who chose ivermectin based on their own research, yielding astonishing outcomes that raise urgent questions about repurposed drugs in oncology. The first, Paul Mann, a 53-year-old marathoner from Phoenix with no family history of cancer, was diagnosed with stage 4 prostate cancer two months after his second Pfizer vaccine. Given three weeks to live, with hospice called, Paul started ivermectin. Slowly, his condition improved; today, he dances four hours a night, three nights a week. His tumor hasn’t fully regressed, but he’s exploring other repurposed medications, a far cry from his initial prognosis. The second patient, Eddie, a man in his late 60s, had unresectable esophageal carcinoma with two inoperable tumors. Declining chemo and radiation, he took ivermectin alone. Within six weeks, his tumors vanished completely, with no other treatment. The third, a woman with an 18cm pelvic tumor originating from her stomach lining, faced grim odds. After a remarkable surgical resection, liver metastases remained. Post-op, she chose ivermectin, and her liver metastases cleared entirely. Dr. Ruddy cautions that three patients aren’t a clinical trial, but three consecutive, dramatic responses in such dire cases are striking. She believes “there’s something going on here that looks important.” Frustrated by the pharmaceutical industry’s disinterest, as well as the lack of support from academic institutions and philanthropies—none of whom she expects to fund ivermectin research due to its low cost—she’s strategizing a scientifically sound, ethical approach to study whether ivermectin and other repurposed drugs can improve cancer survival. These anecdotes aren’t definitive evidence but compel us to ask: could repurposed drugs hold untapped potential for cancer treatment? Rigorous research is needed to find out.

Three Cancer Patients Defy Odds with Ivermectin: A Doctor’s Call for Urgent Research Dr. Kathleen Ruddy, a breast cancer surgeon, author, and inventor, shared remarkable stories of three patients with advanced, aggressive cancers who chose ivermectin based on their own research, yielding astonishing outcomes that raise urgent questions about repurposed drugs in oncology. The first, Paul Mann, a 53-year-old marathoner from Phoenix with no family history of cancer, was diagnosed with stage 4 prostate cancer two months after his second Pfizer vaccine. Given three weeks to live, with hospice called, Paul started ivermectin. Slowly, his condition improved; today, he dances four hours a night, three nights a week. His tumor hasn’t fully regressed, but he’s exploring other repurposed medications, a far cry from his initial prognosis. The second patient, Eddie, a man in his late 60s, had unresectable esophageal carcinoma with two inoperable tumors. Declining chemo and radiation, he took ivermectin alone. Within six weeks, his tumors vanished completely, with no other treatment. The third, a woman with an 18cm pelvic tumor originating from her stomach lining, faced grim odds. After a remarkable surgical resection, liver metastases remained. Post-op, she chose ivermectin, and her liver metastases cleared entirely. Dr. Ruddy cautions that three patients aren’t a clinical trial, but three consecutive, dramatic responses in such dire cases are striking. She believes “there’s something going on here that looks important.” Frustrated by the pharmaceutical industry’s disinterest, as well as the lack of support from academic institutions and philanthropies—none of whom she expects to fund ivermectin research due to its low cost—she’s strategizing a scientifically sound, ethical approach to study whether ivermectin and other repurposed drugs can improve cancer survival. These anecdotes aren’t definitive evidence but compel us to ask: could repurposed drugs hold untapped potential for cancer treatment? Rigorous research is needed to find out.

Camus

38,022 次观看 • 1 年前